Swissmedic approves Pfizer-BioNTech booster shots from the age of 16


Reuters | Zurich | Updated: 23-11-2021 14:35 IST | Created: 23-11-2021 14:27 IST
Swissmedic approves Pfizer-BioNTech booster shots from the age of 16
Representative image Image Credit: ANI
  • Country:
  • United States

Swiss drugs regulator Swissmedic said on Tuesday it approved the extension of a booster dose of Pfizer-BioNTech's COVID-19 vaccine to everyone aged 16 years and over.

"This clears the way for wider use of the booster vaccination. High-risk individuals can still obtain a booster dose from age 12," Swissmedic said in a statement.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback